- 20/9/21 - 1 formulario, 17 itemgroups, 144 items, 1 idioma

Itemgroups: General Information, GENERAL INFORMATION, GENERAL INFORMATION, BONE MARROW FAILURE SYNDROME (INCLUDING APLASTIC ANAEMIA), SUBCLASSIFICATION, CYTOGENETICS, HAEMATOLOGICAL VALUES, COMPLICATIONS, PNH TESTS, FIRST IMMUNOSUPPRESSIVE TREATMENT EPISODE, IF 1ST TREATMENT EPISODE FOR THE PATIENT EVER, IF PATIENT HAS BEEN TREATED BEFORE, ADDITIONAL IMMUNOSUPPRESSIVE TREATMENT EPISODE, STATUS AT HSCT, ADDITIONAL TREATMENT POST-HSCT, BEST DISEASE RESPONSE AT 100 DAYS POST-HSCT, FORMS TO BE FILLED IN

• Registries
• Anemia, Aplastic

- 28/11/17 - 1 formulario, 7 itemgroups, 108 items, 1 idioma

Itemgroups: FOLLOW UP Aplastic Anemia, OTHER COMPLICATIONS SINCE LAST REPORT, GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT, LAST DISEASE AND PATIENT STATUS, ADDITIONAL THERAPIES SINCE LAST FOLLOW UP, GRAFT ASSESSMENT AND HAEMOPOIETIC CHIMAERISM, ADDITIONAL NOTES IF APPLICABLE

• Follow-Up Studies
• Anemia, Aplastic

- 6/8/14 - 1 formulario, 4 itemgroups, 11 items, 2 idiomas

Itemgroups: Show identification of patient, Conditioning chemo therapy generic, Day of administration, Further administration (outside range of -1 to -15)

• Anemia, Aplastic
• Graft vs Host Disease
• Treatment Form
• Clinical Trial

- 6/8/14 - 1 formulario, 7 itemgroups, 15 items, 2 idiomas

Itemgroups: Show identification of patient, GvHD prophylaxis CSA, GvHD prophylaxis CSA application, GvHD prophylaxis MTX, GvHD prophylaxis MTX application, Other drug for GvHD prophylaxis, Other drug application for GvHD prophylaxis

• Anemia, Aplastic
• Graft vs Host Disease
• Clinical Trial
• Disease Status

- 6/8/14 - 1 formulario, 2 itemgroups, 6 items, 2 idiomas

Itemgroups: Show identification of patient, General HSCT data

• Anemia, Aplastic
• Clinical Trial
• Graft vs Host Disease
• Treatment Form

- 6/8/14 - 1 formulario, 6 itemgroups, 10 items, 2 idiomas

Itemgroups: Show identification of patient, radiotherapy given, Conditioning radiotherapy admistration, Radionuclide therapy, Day of administration, Further administration (outside range of -1 to -15)

• Anemia, Aplastic
• Radiotherapy
• Clinical Trial

- 6/8/14 - 1 formulario, 3 itemgroups, 8 items, 2 idiomas

Itemgroups: Show identification of patient, G-CSF immediate after HSCT, Other cytokine immediate after HSCT

• Anemia, Aplastic
• Clinical Trial
• Laboratories

- 6/8/14 - 1 formulario, 5 itemgroups, 45 items, 2 idiomas

Itemgroups: Show identification of patient, Chemistry, HLA Type, Markers of infection, Fanconi anemia

• Anemia, Aplastic
• Laboratories
• Clinical Trial

- 6/8/14 - 1 formulario, 2 itemgroups, 2 items, 2 idiomas

Itemgroups: Show identification of patient, GvHD occurred

• Anemia, Aplastic
• Clinical Trial
• Disease Status

- 6/8/14 - 1 formulario, 7 itemgroups, 45 items, 2 idiomas

Itemgroups: Show identification of patient, Clinical features, Hepatitis, Respiratory symptoms, Bleeding site, Type of other symptoms, Organ dysfunction

• Anemia, Aplastic
• Baseline
• Clinical Trial

- 6/8/14 - 1 formulario, 2 itemgroups, 12 items, 2 idiomas

Itemgroups: Show identification of patient, Graft

• Anemia, Aplastic
• Clinical Trial
• Specimen

- 6/8/14 - 1 formulario, 21 itemgroups, 79 items, 2 idiomas

Itemgroups: Show identification of patient, IST FUP, Immunosuppressive Therapy - Steroids in given interval, Immunosuppressive Therapy - Cyclosporin A, Immunosuppressive Therapy - Cyclosporin A, Immunosuppressive Therapy - G-CSF, Complications - Infection, Complications - EBV PCR, Complications - EBV LPD, Complications - EBV LPD symptoms, Complications - EBV LPD site, Complications - EBV LPD treatment, Complications - Hemorrhage, Complications - Renal/Metabolic Lab., Creatinine, Complications - Other type of complication, Response - Transfusions, Response - Transfusion PLT, Response - Transfusion RBC, Response - Complete blood count, Response, Study centre specific variables

• Follow-Up Studies
• Anemia, Aplastic
• Clinical Trial